Capital Fund Management S.A. Novavax Inc Put Options Transaction History

Capital Fund Management S.A.

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2023 May 15, 2023	SELL	$5.76 - $12.48 $553,536 - $1.2 Million	-96,100 Reduced 63.64%	54,900 $380,000
Q4 2022 Feb 13, 2023	SELL	$8.86 - $25.04 $267,572 - $756,208	-30,200 Reduced 16.67%	151,000 $1.55 Million
Q3 2022 Nov 14, 2022	BUY	$18.2 - $76.12 $1.45 Million - $6.08 Million	79,900 Added 78.87%	181,200 $3.3 Billion
Q2 2022 Aug 12, 2022	SELL	$36.28 - $75.29 $6.18 Million - $12.8 Million	-170,400 Reduced 62.72%	101,300 $5.21 Million
Q1 2022 May 12, 2022	BUY	$69.73 - $142.9 $18.1 Million - $37 Million	259,200 Added 2073.6%	271,700 $20 Million
Q4 2021 Feb 10, 2022	SELL	$134.56 - $217.97 $255,664 - $414,143	-1,900 Reduced 13.19%	12,500 $1.79 Million
Q3 2021 Nov 12, 2021	BUY	$177.8 - $270.58 $746,760 - $1.14 Million	4,200 Added 41.18%	14,400 $2.99 Million
Q2 2021 Aug 12, 2021	BUY	$121.0 - $257.67 $1.23 Million - $2.63 Million	10,200 New	10,200 $2.17 Million

290

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $662M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.